Skip to main content

LA36 Pill - pink capsule-shape, 20mm

Pill with imprint LA36 is Pink, Capsule-shape and has been identified as Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate 600 mg / 200 mg / 300 mg. It is supplied by Laurus Labs Limited.

Efavirenz/emtricitabine/tenofovir is used in the treatment of nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is positive evidence of human fetal risk during pregnancy. Efavirenz/emtricitabine/tenofovir 600 mg / 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LA36

Efavirenz, emtricitabine and tenofovir disoproxil fumarate 600 mg / 200 mg / 300 mg LA36

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate

600 mg / 200 mg / 300 mg
20.00 mm
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Laurus Labs Limited
National Drug Code (NDC)
Inactive Ingredients
croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, ferrosoferric oxide, polyethylene glycol, ferric oxide red, talc, titanium dioxide, polyvinyl alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.